Free Trial

Core Laboratories (CLB) News Today

Core Laboratories logo
$15.48 -0.08 (-0.51%)
As of 03/25/2025 03:58 PM Eastern
Core Laboratories Inc. stock logo
41,381 Shares in Core Laboratories Inc. (NYSE:CLB) Purchased by Intech Investment Management LLC
Intech Investment Management LLC purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 41,381 shares of the oil and gas company's stock, val
Core Laboratories Inc. stock logo
Raymond James Financial Inc. Takes Position in Core Laboratories Inc. (NYSE:CLB)
Raymond James Financial Inc. bought a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 390,554 shares of the oil and
Core Laboratories Inc. stock logo
Charles Schwab Investment Management Inc. Lowers Holdings in Core Laboratories Inc. (NYSE:CLB)
Charles Schwab Investment Management Inc. lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 499,299 shares of the oil and
Core Laboratories Inc. stock logo
Core Laboratories Inc. (NYSE:CLB) Stake Boosted by Amundi
Amundi grew its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 194.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,968 shares of the oil and gas company's stock a
Core Laboratories Inc. stock logo
Royce & Associates LP Reduces Holdings in Core Laboratories Inc. (NYSE:CLB)
Royce & Associates LP lowered its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 969,128 shares of the oil and gas company's stock after selling 51,993 shares during t
Core Laboratories Inc. stock logo
Bank of New York Mellon Corp Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB)
Bank of New York Mellon Corp decreased its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 450,013 shares of the oil and gas company's stock after sellin
Core Laboratories Inc. stock logo
Wintrust Investments LLC Sells 28,549 Shares of Core Laboratories Inc. (NYSE:CLB)
Wintrust Investments LLC decreased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 73.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,142 shares of the oil and gas company's stock after selling 28,549 shares during the peri
Core Laboratories upgraded to Neutral from Sell at Citi
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Upgraded at Citigroup
Citigroup upgraded shares of Core Laboratories from a "sell" rating to a "neutral" rating and boosted their target price for the company from $15.00 to $16.00 in a research report on Wednesday.
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Shares Down 4.9% - Here's Why
Core Laboratories (NYSE:CLB) Stock Price Down 4.9% - Should You Sell?
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Hits New 52-Week Low - What's Next?
Core Laboratories (NYSE:CLB) Hits New 52-Week Low - Here's Why
Core Laboratories Inc. stock logo
Fisher Asset Management LLC Cuts Stake in Core Laboratories Inc. (NYSE:CLB)
Fisher Asset Management LLC lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 941,269 shares of the oil and gas c
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Hits New 12-Month Low - Here's What Happened
Core Laboratories (NYSE:CLB) Sets New 1-Year Low - Time to Sell?
Core Laboratories Inc. stock logo
Citigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) Stock
Citigroup boosted their price target on Core Laboratories from $14.00 to $15.00 and gave the company a "sell" rating in a report on Thursday.
Core Laboratories price target raised to $15 from $14 at Citi
Core Laboratories Inc. stock logo
Kornitzer Capital Management Inc. KS Makes New Investment in Core Laboratories Inc. (NYSE:CLB)
Kornitzer Capital Management Inc. KS purchased a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 35,515 shares of the oil and gas company's
Core Laboratories Inc. stock logo
Rice Hall James & Associates LLC Makes New $1.96 Million Investment in Core Laboratories Inc. (NYSE:CLB)
Rice Hall James & Associates LLC acquired a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 113,203 shares of the oil and ga
Core Laboratories Inc. stock logo
Van ECK Associates Corp Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB)
Van ECK Associates Corp grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 443,621 shares of the oil and gas company's stock after acq
Stifel Nicolaus Remains a Hold on Core Laboratories (CLB)
Core Laboratories Inc. stock logo
Boston Trust Walden Corp Raises Stake in Core Laboratories Inc. (NYSE:CLB)
Boston Trust Walden Corp increased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 617,336 shares of the oil and gas company's stock af
Core Laboratories Inc. stock logo
SG Americas Securities LLC Reduces Position in Core Laboratories Inc. (NYSE:CLB)
SG Americas Securities LLC lessened its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 66.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,723 shares of the oil and gas company's stock after
Core Laboratories reports Q4 adjusted EPS 22c, consensus 22c
Core Laboratories NV Profit Rises In Q4, But Misses Estimates
Core Laboratories Inc. stock logo
Core Laboratories Inc. (NYSE:CLB) Announces $0.01 Quarterly Dividend
Core Laboratories Inc. (NYSE:CLB) declared a quarterly dividend on Thursday, January 30th. Shareholders of record on Monday, February 10th will be given a dividend of 0.01 per share by the oil and gas company on Monday, March 3rd. This represents a $0.04 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Monday, February 10th.
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Shares Gap Down - Here's Why
Core Laboratories (NYSE:CLB) Shares Gap Down - Here's Why
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Posts Quarterly Earnings Results, Hits Expectations
Core Laboratories (NYSE:CLB - Get Free Report) issued its quarterly earnings data on Wednesday. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.23. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%.
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Releases Q1 2025 Earnings Guidance
Core Laboratories (NYSE:CLB) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.120-0.160 for the period, compared to the consensus estimate of 0.210. The company also issued revenue guidance of $121.0 millionillion-$127.0 millionillion, compared to the consensus estimate of $131.7 millionillion.
Core Labs Reports Revenue Growth Amid Challenges
Core Laboratories Q4 2024 Earnings Preview
Core Laboratories Inc. stock logo
Core Laboratories (CLB) to Release Earnings on Wednesday
Core Laboratories (NYSE:CLB) will be releasing earnings after the market closes on Wednesday, January 29, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=218718)
Core Laboratories Inc. stock logo
Zacks Research Analysts Lower Earnings Estimates for CLB
Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Core Laboratories in a research report issued to clients and investors on Friday, January 17th. Zacks Research analyst T. Saha now forecasts that the oil and gas com
Core Laboratories Inc. stock logo
Short Interest in Core Laboratories Inc. (NYSE:CLB) Declines By 6.5%
Core Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 6,290,000 shares, a decrease of 6.5% from the December 15th total of 6,730,000 shares. Currently, 13.5% of the company's shares are sold short. Based on an average trading volume of 309,800 shares, the days-to-cover ratio is currently 20.3 days.
Core Laboratories (CLB) Gets a Hold from Stifel Nicolaus
Core Laboratories Inc. stock logo
Barclays PLC Buys 62,042 Shares of Core Laboratories Inc. (NYSE:CLB)
Barclays PLC boosted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,570 shares of the oil and gas company's stock
Core Laboratories Inc. stock logo
Barclays PLC Purchases 62,042 Shares of Core Laboratories Inc. (NYSE:CLB)
Barclays PLC grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,570 shares of the oil and gas company's stock a
Core Laboratories Inc. stock logo
State Street Corp Has $36.60 Million Stock Position in Core Laboratories Inc. (NYSE:CLB)
State Street Corp grew its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,975,016 shares of the oil and gas company's stock after purchasing an
Core Laboratories Inc. stock logo
Core Laboratories (NYSE:CLB) Trading Down 2.6% - Time to Sell?
Core Laboratories (NYSE:CLB) Trading Down 2.6% - Should You Sell?
Remove Ads
Get Core Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

CLB Media Mentions By Week

CLB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLB
News Sentiment

1.34

0.76

Average
Energy
News Sentiment

CLB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLB Articles
This Week

5

3

CLB Articles
Average Week

Remove Ads
Get Core Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CLB) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners